Eagle Pharmaceuticals (EGRX) Competitor Comparison
We are evaluating the key criteria listed to compare Eagle Pharmaceuticals (EGRX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
41 / 54Gross Profits
19 / 39Total Revenue
28 / 50EBITDA
21 / 53Free Cashflow
20 / 54Quick Ratio
25 / 54Earnings per Share
10 / 54Dividend yield
0 / 5Total Cash
45 / 54Performance 3 years
51 / 54Performance 5 years
51 / 54Performance 10 years
43 / 54Linearity 3 years
33 / 54Linearity 5 years
37 / 54Linearity 10 years
5 / 54Total Rank
5 / 54Dividend Rank
15 / 54Valuation Rank
1 / 54Piotroski Rank
10 / 54Muliplier Rank
2 / 54Market Capitalization - EGRX ranking 41 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.